Escalon Medical ESMC
OTC ESMC
$0.19 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Escalon Medical (ESMC) Gains from Sales and Divestitures (2013 - 2026)

Updated

Escalon Medical (ESMC) posted Gains from Sales and Divestitures of $2.81 million for FY2026 (year ended Jun 30, 2026).

Analysis

Escalon Medical (ESMC) Gains from Sales and Divestitures (2013 - 2026) Analysis & Trends

Since FY2012, Escalon Medical has reported Gains from Sales and Divestitures for 4 fiscal years.

  • The FY2026 figure stands as the lowest annual Gains from Sales and Divestitures since FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.23 Bn 234.75 Bn 5.13 Bn
2 Abbott Laboratories 189.69 Bn 163.55 Bn 7.39 Bn
3 Danaher 161.73 Bn 141.39 Bn 3.84 Bn
4 Intuitive Surgical 159.20 Bn 139.49 Bn 2.08 Bn
5 Medtronic 130.49 Bn 95.74 Bn 6.34 Bn
6 Stryker 125.08 Bn 111.27 Bn 4.25 Bn
7 Boston Scientific 63.06 Bn 58.50 Bn 3.43 Bn
8 Edwards Lifesciences 59.30 Bn 42.51 Bn 1.35 Bn
9 Becton Dickinson 58.40 Bn 55.55 Bn 2.32 Bn
10 Escalon Medical 1.41 Mn -5.95 Mn 1.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.81 Mn
Mar 31, 2013 2.72 Mn
API Access

Escalon Medical Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ESMC&period=max&api_key=YOUR_API_KEY